ID   A549/DDP
AC   CVCL_C0W4
DR   cancercelllines; CVCL_C0W4
DR   CLS; 305047
DR   Wikidata; Q114310532
RX   PubMed=28114404;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS=305047
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
RX   PubMed=28114404; DOI=10.1371/journal.pone.0170609; PMCID=PMC5256872;
RA   Fang Y.-N., Zhang C., Wu T., Wang Q., Liu J.-H., Dai P.-G.;
RT   "Transcriptome sequencing reveals key pathways and genes associated
RT   with cisplatin resistance in lung adenocarcinoma A549 cells.";
RL   PLoS ONE 12:e0170609.1-e0170609.17(2017).
//